These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9882704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA, Erneux C, Primrose WU, Gigg R, Nahorski SR.
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [Abstract] [Full Text] [Related]

  • 4. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT, Riley AM, Lindley CJ, Jenkins DJ, Westwick J, Potter BV.
    Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Structural determinants of adenophostin A activity at inositol trisphosphate receptors.
    Correa V, Riley AM, Shuto S, Horne G, Nerou EP, Marwood RD, Potter BV, Taylor CW.
    Mol Pharmacol; 2001 May; 59(5):1206-15. PubMed ID: 11306705
    [Abstract] [Full Text] [Related]

  • 8. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA, Fauq A, Kozikowski AP, Nahorski SR.
    FEBS Lett; 1997 Feb 03; 402(2-3):241-5. PubMed ID: 9037203
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interaction.
    Rosenberg HJ, Riley AM, Laude AJ, Taylor CW, Potter BV.
    J Med Chem; 2003 Nov 06; 46(23):4860-71. PubMed ID: 14584937
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group.
    Schäfer R, Nehls-Sahabandu M, Grabowsky B, Dehlinger-Kremer M, Schulz I, Mayr GW.
    Biochem J; 1990 Dec 15; 272(3):817-25. PubMed ID: 2176480
    [Abstract] [Full Text] [Related]

  • 13. Rapid kinetic measurements of 45Ca2+ mobilization reveal that Ins(2,4,5)P3 is a partial agonist at hepatic InsP3 receptors.
    Marchant JS, Chang YT, Chung SK, Irvine RF, Taylor CW.
    Biochem J; 1997 Feb 01; 321 ( Pt 3)(Pt 3):573-6. PubMed ID: 9032438
    [Abstract] [Full Text] [Related]

  • 14. Conformational changes in plant Ins(1,4,5)P3 receptor on interaction with different myo-inositol trisphosphates and its effect on Ca2+ release from microsomal fraction and liposomes.
    Dasgupta S, Dasgupta D, Chatterjee A, Biswas S, Biswas BB.
    Biochem J; 1997 Jan 15; 321 ( Pt 2)(Pt 2):355-60. PubMed ID: 9020866
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT, Bullock AJ, Lindley CJ, Mills SJ, Riley AM, Potter BV, Westwick J.
    Mol Pharmacol; 1996 Nov 15; 50(5):1223-30. PubMed ID: 8913354
    [Abstract] [Full Text] [Related]

  • 17. Calcium mediates the interconversion between two states of the liver inositol 1,4,5-trisphosphate receptor.
    Pietri F, Hilly M, Mauger JP.
    J Biol Chem; 1990 Oct 15; 265(29):17478-85. PubMed ID: 2170381
    [Abstract] [Full Text] [Related]

  • 18. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST, Wilcox RA, Liu C, Dubreuil D, Potter BV, Nahorski SR.
    Mol Pharmacol; 1993 Apr 15; 43(4):499-503. PubMed ID: 8386304
    [Abstract] [Full Text] [Related]

  • 19. Inositol 1,4,5-trisphosphate receptor subtypes differentially recognize regioisomers of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M, Takeuchi H, Riley AM, Mills SJ, Watanabe Y, Potter BV.
    Biochem J; 1997 Nov 15; 328 ( Pt 1)(Pt 1):93-8. PubMed ID: 9359838
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of elementary Ca2+ puffs evoked in Xenopus oocytes by different Ins(1,4,5)P3 receptor agonists.
    Marchant JS, Parker I.
    Biochem J; 1998 Sep 15; 334 ( Pt 3)(Pt 3):505-9. PubMed ID: 9729454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.